The Non-Vesicular Cholesterol Transporter GRAMD1C is a Pan-Coronavirus Antiviral Target

0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Coronaviruses (CoVs) rely heavily on host lipid metabolism for efficient replication, but the specific host pathways involved remain incompletely defined. Here, we identify the non-vesicular cholesterol transport protein GRAMD1C as a key host factor required for the replication of multiple coronaviruses across α, β, and δ genera, including TGEV, PEDV, HCoV-229E, SARS-CoV-2, MHV, and PDCoV. Mechanisti­cally, GRAMD1C is recruited to the replication factory through its interaction with the viral nonstructural proteins 3 and 4 (nsp3 and nsp4). Transmission electron micros­copy (TEM) analysis revealed that GRAMD1C facilitates the formation of replication double-membrane vesicles (DMVs). Further domain rescue and inhibitor experiments demonstrated that GRAMD1C’s cholesterol transport activity is essential for viral rep­lication. Moreover, GRAMD1C-deficient and inhibitor-treated mice exhibited reduced viral replication, underscoring its critical role in vivo. Collectively, our findings expand the current understanding of the importance of non-vesicular cholesterol transport in viral replication and highlight GRAMD1C as a promising broad-spectrum antiviral target.

Cite

CITATION STYLE

APA

Zhelin, S., Zhen, F., Yichen, Y., Yanan, F., Jingwen, M., Juan, X., … Guiqing, P. (2026). The Non-Vesicular Cholesterol Transporter GRAMD1C is a Pan-Coronavirus Antiviral Target. PLOS Biology, 24(4), 1–25. https://doi.org/10.1371/JOURNAL.PBIO.3003736

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free